Robert Olstein Johnson & Johnson Transaction History

Olstein Capital Management, L.P.

$588 Million
Q3 2024

A detailed history of Robert Olstein (Olstein Capital Management, L.P.) transactions in Johnson & Johnson stock. As of the latest transaction made, Olstein Capital Management, L.P. holds 61,000 shares of JNJ stock, worth $9.34 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares

61,000

Previous 61,000 -0.0%

Holding current value

$9.34 Million

Previous $8.92 Million 10.88%

% of portfolio

1.68%

Previous 1.59%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	BUY	$144.38 - $157.78 $144,380 - $157,780	1,000 Added 1.67%	61,000 $8.92 Million
Q1 2023 May 02, 2023	BUY	$151.05 - $180.26 $1.81 Million - $2.16 Million	12,000 Added 25.0%	60,000 $9.3 Million
Q4 2022 Feb 06, 2023	SELL	$160.2 - $179.79 $1.6 Million - $1.8 Million	-10,000 Reduced 17.24%	48,000 $8.48 Million
Q3 2022 Oct 27, 2022	BUY	$161.33 - $179.52 $241,995 - $269,280	1,500 Added 2.65%	58,000 $9.48 Million
Q3 2022 Oct 19, 2022	SELL	$161.33 - $179.52 $725,985 - $807,840	-4,500 Reduced 7.38%	56,500 $8.54 Million
Q2 2022 Jul 25, 2022	SELL	$168.19 - $186.01 $1.68 Million - $1.86 Million	-10,000 Reduced 14.08%	61,000 $10.8 Million
Q4 2021 Jan 27, 2022	BUY	$155.93 - $173.01 $1.09 Million - $1.21 Million	7,000 Added 10.94%	71,000 $12.1 Million
Q1 2021 May 13, 2021	BUY	$153.07 - $170.48 $2.91 Million - $3.24 Million	19,000 Added 42.22%	64,000 $10.5 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $1.51 Million - $1.73 Million	11,000 Added 32.35%	45,000 $7.08 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $1.12 Million - $1.23 Million	8,000 Added 30.77%	34,000 $5.06 Million
Q2 2020 Aug 12, 2020	BUY	$128.81 - $155.51 $3.35 Million - $4.04 Million	26,000 New	26,000 $3.66 Million

Others Institutions Holding JNJ

# of Institutions

4,270

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track Robert Olstein's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Olstein Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Olstein Capital Management, L.P. and Robert Olstein with notifications on news.

Account